Design, synthesis, and anti-influenza A virus evaluation of 2-aminoquinoline derivatives.
Derby 3g significantly reduced viral loads in the lungs of infected mice, alleviated pulmonary histopathological damage, and downregulated inflammatory factor levels, while exhibiting good biosafety, placing it as a promising compound for the development of novel anti-influenza therapies.